The WiSE CRT system (formerly the WiCS-LV) is a wireless left ventricular pacing system that works with a conventional pacemaker and/or defibrillator for patients in whom cardiac resynchronization therapy (CRT) is indicated. The WiSE CRT system is comprised of an ultrasonic transmitter attached to a battery unit and a tiny wireless receiver which acts as a pacing electrode. T…
Publications
Hayes Publications are available through the Hayes Knowledge Center, a portal to world-class research and unbiased analyses on the clinical, financial, and risk impacts of emerging, controversial, and disruptive healthcare technologies.Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.
See below for some of our recent publications.
Pulsed Radiofrequency Application to the Dorsal Root Ganglion for Treatment of Cervical Radicular Pain
Health Problem: Cervical radicular pain may be caused by cervical degenerative disc disease, herniated disc, spinal stenosis, and foraminal stenosis. Symptoms include pain with upper extremity radiation, paresthesias in the arm or hand in conjunction with diminished muscle tendon reflexes, sensory loss, or motor weakness. Symptoms most often follow the distribution pattern of …
Elzonris (Tagraxofusp-erzs) for Blastic Plasmacytoid Dendritic Cell Neoplasm
Elzonris is a recombinant protein consisting of human interleukin-3 (IL-3) conjugated with diphtheria toxin that is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm. This protein binds to the IL-3 receptor subunit alpha chain (CD123), preventing protein synthesis and prompting cell death.
Elzonris (Tagraxofusp-erzs) for Blastic Plasmacytoid Dendritic Cell Neoplasm
Elzonris is a recombinant protein consisting of human interleukin-3 (IL-3) conjugated with diphtheria toxin that is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm. This protein binds to the IL-3 receptor subunit alpha chain (CD123), preventing protein synthesis and prompting cell death.
Humacyl Acellular Vessel
Humacyl is an off-the-shelf bioengineered human acellular vessel proposed for use as a hemodialysis access graft in patients with end stage renal disease (ESRD). This technology uses a process to decellularize donated human vascular smooth muscle cells, while preserving extracellular matrix proteins. This results in a tubular scaffold that is acellular at the time of implanta…
Acoustic Radiation Force Impulse (ARFI) Elastography for Detecting Hepatic Fibrosis in Patients with Hepatitis C
Health Problem: Approximately 3.2 million people in the United States have a chronic hepatitis C virus (HCV) infection, which puts them at risk for developing hepatic fibrosis or cirrhosis, a need for liver transplantation, and possible death due to liver failure or liver cancer. However, HCV infection is a treatable disease and effective antiviral treatments that can lead to …
Comparative Effectiveness Review of Laser Therapy for Psoriasis
Health Problem: Psoriasis is an immune-mediated disease of the skin that affects 7.5 million people in the United States and is characterized by the appearance of red, thickened, scaly patches on the skin.
Technology Description: Laser therapy typically involves passing a focused laser beam back and forth over the entire area of a psoriasis lesion. In s…
Transpyloric Shuttle Device
The TransPyloric Shuttle Device is an endoscopically placed gastric-occupying device for weight reduction in adult patients with a BMI of 35.0 kg/m2 to 40.0 kg/m2 or a BMI of 30.0 kg/m2 to 34.9 kg/m2 with at least 1 obesity-related comorbidit…
Transpyloric Shuttle Device
The TransPyloric Shuttle Device is an endoscopically placed gastric-occupying device for weight reduction in adult patients with a BMI of 35.0 kg/m2 to 40.0 kg/m2 or a BMI of 30.0 kg/m2 to 34.9 kg/m2 with at least 1 obesity-related comorbidit…
Plenity (Gelesis100) for Weight Loss
Plenity (formerly Gelesis100 and GSP3) is an oral, non-systemic, superabsorbent hydrogel intended as an aid in weight management in overweight and obese adults with a body mass index (BMI) of 25-40 kg/m2, when used in conjunction with diet and exercise.